196 related articles for article (PubMed ID: 33293895)
1. High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients.
Lu X; Zhang J; Wang S; Yu Q; Li H
Mediators Inflamm; 2020; 2020():1027230. PubMed ID: 33293895
[TBL] [Abstract][Full Text] [Related]
2. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.
Ogawa T; Shimizu H; Kyono A; Sato M; Yamashita T; Otsuka K; Nitta K
Int Urol Nephrol; 2014 Jan; 46(1):151-9. PubMed ID: 23807369
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Altitude on Erythropoietin Resistance Index in Maintenance Hemodialysis Patients: Data from Tibetan Plateau.
Wang Y; Dang ZH; Gan LY; Luobu C; Zhang L; Li GL; Zuo L
Blood Purif; 2021; 50(3):364-369. PubMed ID: 33091903
[TBL] [Abstract][Full Text] [Related]
4. Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis.
Chung S; Song HC; Shin SJ; Ihm SH; Park CS; Kim HY; Yang CW; Kim YS; Choi EJ; Kim YK
Hemodial Int; 2012 Apr; 16(2):181-7. PubMed ID: 22103889
[TBL] [Abstract][Full Text] [Related]
5. The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients.
Zhao X; Gan L; Hou FF; Liang X; Chen X; Chen Y; Ni Z; Zuo L
Ren Fail; 2024 Dec; 46(1):2290922. PubMed ID: 38234178
[TBL] [Abstract][Full Text] [Related]
6. Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.
Bae MN; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
PLoS One; 2015; 10(11):e0143348. PubMed ID: 26588085
[TBL] [Abstract][Full Text] [Related]
7. Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study.
Fujii H; Hamano T; Tsuchiya K; Kuragano T; Joki N; Tsuruya K; Honda H; Uemura Y; Nitta K;
Int J Cardiol; 2023 Mar; 375():110-118. PubMed ID: 36592827
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
10. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
Petrulienė K; Žiginskienė E; Kuzminskis V; Nedzelskienė I; Bumblytė IA
Medicina (Kaunas); 2017; 53(2):90-100. PubMed ID: 28416170
[TBL] [Abstract][Full Text] [Related]
12. Association between Serum Magnesium and Erythropoietin Responsiveness in Hemodialysis Patients: A Cross-Sectional Study.
Yu L; Song J; Lu X; Zu Y; Li H; Wang S
Kidney Blood Press Res; 2019; 44(3):354-361. PubMed ID: 31189174
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio and Erythropoietin Resistance among Maintenance Hemodialysis Patients.
Zhang J; Lu X; Wang S; Li H
Blood Purif; 2022; 51(8):708-713. PubMed ID: 34649238
[TBL] [Abstract][Full Text] [Related]
15. Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients.
Pan S; Zhao DL; Li P; Sun XF; Zhou JH; Song KK; Wang Y; Miao LN; Ni ZH; Lin HL; Liu FY; Li Y; He YN; Wang NS; Wang CL; Zhang AH; Chen MH; Yang XP; Deng YY; Shao FM; Fu SX; Fang JA; Cai GY; Chen XM
Blood Purif; 2022; 51(2):171-181. PubMed ID: 34175850
[TBL] [Abstract][Full Text] [Related]
16. The predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysis.
Kim JK; Park BS; Park MJ; Choi W; Ma SK; Nah MY; Yeum CH; Jung K; Lee SC; Kim SW; Kim NH; Kang YJ; Choi KC
Korean J Intern Med; 2001 Jun; 16(2):110-7. PubMed ID: 11590897
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.
Guerrero-Riscos MÁ; Montes-Delgado R; Seda-Guzmán M; Praena-Fernández JM
Nefrologia; 2012 May; 32(3):343-52. PubMed ID: 22535158
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
[TBL] [Abstract][Full Text] [Related]
19. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.
Rattanasompattikul M; Molnar MZ; Zaritsky JJ; Hatamizadeh P; Jing J; Norris KC; Kovesdy CP; Kalantar-Zadeh K
Nephrol Dial Transplant; 2013 Jul; 28(7):1936-45. PubMed ID: 23045431
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia.
Hu JP; Cheng X; Xu XF; Yu GJ; Luo F; Zhang GS; Yang N; Shen P; Yan XY
J Biol Regul Homeost Agents; 2016; 30(2):535-40. PubMed ID: 27358145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
